Next Article in Journal
Chemical Composition of Volatile Compounds in Apis mellifera Propolis from the Northeast Region of Pará State, Brazil
Previous Article in Journal
Epilobium angustifolium L. Extracts as Valuable Ingredients in Cosmetic and Dermatological Products
Article

Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues

1
Research Genetic Cancer Centre S.A. Industrial Area of Florina, GR53100 Florina, Greece
2
Research Genetic Cancer Centre International GmbH, Baarerstrasse, 95, 6301 Zug, Switzerland
*
Author to whom correspondence should be addressed.
Academic Editor: Diego Muñoz-Torrero
Molecules 2021, 26(11), 3461; https://doi.org/10.3390/molecules26113461
Received: 5 May 2021 / Revised: 26 May 2021 / Accepted: 2 June 2021 / Published: 7 June 2021
(This article belongs to the Section Medicinal Chemistry)
Despite the fact that COVID-19 vaccines are already available on the market, there have not been any effective FDA-approved drugs to treat this disease. There are several already known drugs that through drug repositioning have shown an inhibitory activity against SARS-CoV-2 RNA-dependent RNA polymerase. These drugs are included in the family of nucleoside analogues. In our efforts, we synthesized a group of new nucleoside analogues, which are modified at the sugar moiety that is replaced by a quinazoline entity. Different nucleobase derivatives are used in order to increase the inhibition. Five new nucleoside analogues were evaluated with in vitro assays for targeting polymerase of SARS-CoV-2. View Full-Text
Keywords: nucleoside derivatives; COVID-19; quinazoline moiety nucleoside derivatives; COVID-19; quinazoline moiety
Show Figures

Graphical abstract

MDPI and ACS Style

Daikopoulou, V.; Apostolou, P.; Mourati, S.; Vlachou, I.; Gougousi, M.; Papasotiriou, I. Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues. Molecules 2021, 26, 3461. https://doi.org/10.3390/molecules26113461

AMA Style

Daikopoulou V, Apostolou P, Mourati S, Vlachou I, Gougousi M, Papasotiriou I. Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues. Molecules. 2021; 26(11):3461. https://doi.org/10.3390/molecules26113461

Chicago/Turabian Style

Daikopoulou, Vasiliki, Panagiotis Apostolou, Sofia Mourati, Ioanna Vlachou, Maria Gougousi, and Ioannis Papasotiriou. 2021. "Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues" Molecules 26, no. 11: 3461. https://doi.org/10.3390/molecules26113461

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop